CA Patent

CA3110658A1 — Compounds, compositions and methods for treating or preventing her-driven cancers

Assigned to Rain Therapeutics Inc · Expires 2020-03-19 · 6y expired

What this patent protects

Disclosed herein are methods of treating or preventing HER-driven cancers. In some embodiments, the cancer comprises lung cancer or brain metastases.

USPTO Abstract

Disclosed herein are methods of treating or preventing HER-driven cancers. In some embodiments, the cancer comprises lung cancer or brain metastases.

Drugs covered by this patent

Patent Metadata

Patent number
CA3110658A1
Jurisdiction
CA
Classification
—
Expires
2020-03-19
Drug substance claim
No
Drug product claim
No
Assignee
Rain Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.